OpenAlex
PricingAboutJobs
Log inGet started
Work

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma

HTML

Year: 2013
Type: article
Source: Journal of Immunotherapy
DOI: 10.1097/cji.0b013e31828eed39
Authors: Sofie Wilgenhof, Stephanie Du Four, Frederik Vandenbroucke, Hendrik Everaert, Isabelle Salmon, Danielle Liénard, Véronique Del Marmol, Bart Neyns
Institutions: Universitair Ziekenhuis Brussel, Erasmus Hospital
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ipilimumab, advanced melanoma, CTLA-4 blockade, expanded access program, reinduction therapy, immune-related adverse events, overall survival, C-reactive protein, absolute lymphocyte count, prognostic factors, objective response rate
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2042576421
FWCI: 7.95
Cites:
Cited by: 96
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security